Early STEP-HFpEF outcomes were presented back in April at ACC.24, the annual meeting of the American College of Cardiology
Like Anton, Sylejmani noted that what the study found aligns with observations in my practice, where patients on these medications have reported decreased cravings for sugar and alcohol. Xu noted that the findings provide strong evidence supporting future randomized clinical trials to test semaglutide for alcohol use disorders. Although further research is needed to confirm the results, Anton highlighted that the potential implications of this research are significant. For patients and the public, it means that medications primarily used for diabetes and weight loss could also help reduce alcohol dependence, addressing two major health issues concurrently. Mark A
Perfect for layering under sunscreen or body care products, it complements any skincare routine
Turer, E
A Leading Supplier in the UK We take pride in being a trusted supplier of retatrutide and other premium research peptides across the UK
Genetzakis E, Gilchrist J, Kassiou M, Figtree GA
